News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Reflect Scientific, Inc. Strengthens Liquid Nitrogen Cooling Intellectual Property Position



11/1/2011 7:38:04 AM

OREM, UT--(Marketwire - November 01, 2011) -

Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced another published patent application for the liquid nitrogen cooled refrigeration system for the transportation industry.

Reflect Scientific continues to build a strong intellectual property portfolio around the liquid nitrogen cooling technology that is used in refrigerated trailers for the transportation of perishable goods. The regeneration system described in the latest application eliminates the need for batteries or other external power sources making the system self-contained. "The Cryometrix B-120 has reached a stage where it has become the most environmentally responsible cooling system for transportation on the market," remarked Thomas Tait, Vice President of Reflect Scientific.

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. For more information, visit www.reflectscientific.com.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.


Contact:

Thomas Tait
Vice President
719-357-5878


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES